,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,13,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
6,15,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
7,19,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
8,21,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
9,23,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
10,25,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
11,29,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
12,33,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
13,35,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
14,37,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
15,39,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
16,41,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
17,43,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
18,45,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
19,47,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
20,49,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
21,53,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
22,55,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
23,59,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
24,65,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
25,67,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
26,71,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
27,73,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
28,77,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
29,79,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
30,81,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
31,83,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
32,85,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
33,87,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
34,91,1,1,,73808,222284,Unspecified,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
35,93,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
36,95,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
37,97,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Confirmatory,,
38,99,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
39,101,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
40,105,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
41,107,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
42,109,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
43,113,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
44,115,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
45,119,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
46,121,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
47,123,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
48,125,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
49,131,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
50,137,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
51,139,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
52,141,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
53,143,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
54,145,1,1,,73808,222284,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
55,155,1,1,,73808,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
56,155,1,1,,101391,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
57,157,1,1,,73808,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
58,157,1,1,,101391,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
59,161,1,1,,73808,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
60,161,1,1,,101391,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
61,165,1,1,,73808,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
62,165,1,1,,101391,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
63,167,1,1,,73808,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
64,167,1,1,,101391,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
65,175,1,1,,73808,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
66,175,1,1,,101391,222284,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
67,192,1,1,,101391,222284,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
68,248,1,1,,73808,222284,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
69,248,1,1,,101391,222284,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
70,256,1,1,,101391,222284,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
71,270,1,1,,101391,222284,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
72,316,1,1,,101391,222284,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P1534 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
73,328,1,1,,101391,222284,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
74,1195,1,2,,48416544,222284,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
75,1204,1,2,,48421987,222284,Inactive,,,,,DSSTox (NCTRER) National Center for Toxicological Research Estrogen Receptor Binding Database,Screening,,
76,1332,1,1,,49699231,222284,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
77,2517,2,1,,144205067,222284,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
78,278000,8,1,,103507229,222284,Unspecified,,,,,Antitubercular activity against Mycobacterium tuberculosis 90-221387,Other,17315960.0,
79,299888,3,4,,103507229,222284,Active,,,,,Antiproliferative activity against human HT29 cells at 5 uM after 24 hrs by MTT assay,Other,17512744.0,
80,299889,3,3,,103507229,222284,Unspecified,,,,,Growth inhibition of monkey COS1 cells at 0.63 uM after 48 hrs by MTT assay,Other,17512744.0,
81,299890,3,4,,103507229,222284,Active,,,,,Induction of apoptosis in human HT29 cells at 5 uM,Other,17512744.0,
82,299891,3,3,,103507229,222284,Unspecified,,,,,Growth inhibition of monkey COS1 cells at 1.25 uM after 48 hrs by MTT assay,Other,17512744.0,
83,299892,3,3,,103507229,222284,Unspecified,,,,,Growth inhibition of monkey COS1 cells at 2.5 uM after 48 hrs by MTT assay,Other,17512744.0,
84,299893,3,3,,103507229,222284,Unspecified,,,,,Growth inhibition of monkey COS1 cells at 5 uM after 48 hrs by MTT assay,Other,17512744.0,
85,311138,6,2,,103507229,222284,Unspecified,,,241.1,IC50,Antitrypanosomal activity against Trypanosoma brucei brucei bloodstream trypomastigotes by alamar blue assay,Confirmatory,17637068.0,
86,311139,6,2,,103507229,222284,Unspecified,,,241.1,IC50,Cytotoxicity against mouse J774 cells by alamar blue assay,Confirmatory,17637068.0,
87,315606,3,4,,103507229,222284,Unspecified,,,,,Growth inhibition of human BGC823 cells at 5 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
88,315607,3,4,,103507229,222284,Unspecified,,,,,Growth inhibition of human BGC823 cells at 10 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
89,315608,3,4,,103507229,222284,Unspecified,,,,,Growth inhibition of human BGC823 cells at 50 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
90,315609,3,4,,103507229,222284,Unspecified,,,,,Growth inhibition of human BGC823 cells at 100 uM after 72 hrs by MTT assay relative to control,Other,17997321.0,
91,332912,9,1,,103507229,222284,Unspecified,,,,,Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method,Other,8158169.0,
92,337692,4,3,,103507229,222284,Unspecified,,,,,Antibacterial activity against Bacillus subtilis ATCC 6633 after 48 hrs by silica gel plate-based INT-formazan method,Other,3110376.0,
93,337693,4,3,,103507229,222284,Unspecified,,,,,Antibacterial activity against Escherichia coli ATCC 25922 after 48 hrs by silica gel plate-based INT-formazan method,Other,3110376.0,
94,356428,3,7,,103507229,222284,Unspecified,,,,,Inhibition of tyrosinase at 333 uM,Other,14510598.0,
95,356584,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human A549 cells after 3 days by SRB assay,Other,14640511.0,
96,356585,6,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human MCF7 cells after 3 days by SRB assay,Other,14640511.0,
97,356586,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human HCT8 cells after 3 days by SRB assay,Other,14640511.0,
98,356587,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human KB cells after 3 days by SRB assay,Other,14640511.0,
99,356588,6,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human KBVIN cells after 3 days by SRB assay,Other,14640511.0,
100,356589,6,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human U87MG cells after 3 days by SRB assay,Other,14640511.0,
101,356590,6,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human PC3 cells after 3 days by SRB assay,Other,14640511.0,
102,356591,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human 1A9 cells after 3 days by SRB assay,Other,14640511.0,
103,356592,6,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human 1A9/PTX10 cells after 3 days by SRB assay,Other,14640511.0,
104,356593,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human 1A9 cells after 6 days by SRB assay,Other,14640511.0,
105,356594,6,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human 1A9/PTX10 cells after 6 days by SRB assay,Other,14640511.0,
106,356610,9,2,,103507229,222284,Active,,,26.3,IC50,Inhibition of DNA polymerase beta lyase activity by deoxyribose phosphate excision assay,Confirmatory,14640519.0,
107,359150,3,5,,103507229,222284,Unspecified,,,,,Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes assessed as cell viability at 100 uM treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay relative to normal hepatocytes,Other,11277757.0,
108,359151,3,5,,103507229,222284,Unspecified,,,,,Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes assessed as cell viability at 50 uM treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay relative to normal hepatocytes,Other,11277757.0,
109,359152,3,5,,103507229,222284,Unspecified,,,,,Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes assessed as cell viability at 25 uM treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay relative to normal hepatocytes,Other,11277757.0,
110,359153,3,5,,103507229,222284,Unspecified,,,,,Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes at 100 uM treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay relative to control,Other,11277757.0,
111,359154,3,5,,103507229,222284,Unspecified,,,,,Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes at 50 uM treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay relative to control,Other,11277757.0,
112,359155,3,5,,103507229,222284,Unspecified,,,,,Hepatoprotective activity against D-galactosamine/TNFalpha-induced cell death in primary cultured mouse hepatocytes at 25 uM treated for 30 mins before TNFalpha challenge measured after 18 hrs by MTT assay relative to control,Other,11277757.0,
113,375386,6,2,,103507229,222284,Active,,,46.22,IC50,Cytotoxicity against human HeLa cells by MTT assay,Confirmatory,19447618.0,
114,375387,6,2,,103507229,222284,Active,,,42.1,IC50,Cytotoxicity against human MCF7 cells by MTT assay,Confirmatory,19447618.0,
115,375388,6,2,,103507229,222284,Unspecified,,,50.0,IC50,Cytotoxicity against human SK-MEL-1 cells by MTT assay,Confirmatory,19447618.0,
116,375389,3,4,,103507229,222284,Unspecified,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition LPS-induced TNFalpha secretion at 0.01 uM after 12 hrs,Other,19447618.0,
117,375391,3,4,,103507229,222284,Unspecified,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition LPS-induced IL6 secretion at 1 uM after 12 hrs,Other,19447618.0,
118,377793,6,2,,103507229,222284,Unspecified,,,,,Antibabesial activity against Babesia gibsoni in dog erythrocytes after 72 hrs,Other,15844943.0,
119,377794,6,2,,103507229,222284,Unspecified,,,,,Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCR3 in human erythrocytes after 24 hrs,Other,15844943.0,
120,377795,3,3,,103507229,222284,Unspecified,,,,,Cytotoxicity against dog RBC,Other,15844943.0,
121,377796,3,3,,103507229,222284,Unspecified,,,,,Cytotoxicity against human RBC,Other,15844943.0,
122,379516,9,1,,103507229,222284,Unspecified,,,,IC50,Cytotoxicity against human A549 cells after 96 hrs by MTT assay,Confirmatory,17125236.0,
123,379517,9,1,,103507229,222284,Unspecified,,,,IC50,Cytotoxicity against human A2780 cells after 96 hrs by MTT assay,Confirmatory,17125236.0,
124,379518,9,1,,103507229,222284,Unspecified,,,,IC50,Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay,Confirmatory,17125236.0,
125,379519,9,1,,103507229,222284,Unspecified,,,,IC50,Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay,Confirmatory,17125236.0,
126,379520,9,1,,103507229,222284,Unspecified,,,,IC50,Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay,Confirmatory,17125236.0,
127,379521,3,8,,103507229,222284,Inactive,,,,,Inhibition of PTP1B at 50 uM,Other,17125236.0,
128,379522,3,8,,103507229,222284,Inactive,,,,,Inhibition of thrombin at 50 uM,Other,17125236.0,
129,383183,6,2,,103507229,222284,Inactive,,,,IC50,Inhibition of Saccharomyces sp. alpha-glucosidase,Confirmatory,18341288.0,
130,388897,3,3,,103507229,222284,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv at 128 ug/mL by microplate alamar blue assay,Other,18818073.0,
131,388898,3,3,,103507229,222284,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv at 64 ug/mL by microplate alamar blue assay,Other,18818073.0,
132,388899,3,3,,103507229,222284,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv at 32 ug/mL by microplate alamar blue assay,Other,18818073.0,
133,388900,3,3,,103507229,222284,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv at 16 ug/mL by microplate alamar blue assay,Other,18818073.0,
134,388901,3,3,,103507229,222284,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv at 8 ug/mL by microplate alamar blue assay,Other,18818073.0,
135,388902,3,3,,103507229,222284,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv at 4 ug/mL by microplate alamar blue assay,Other,18818073.0,
136,388903,3,3,,103507229,222284,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv at 2 ug/mL by microplate alamar blue assay,Other,18818073.0,
137,389101,6,2,,103507229,222284,Unspecified,,,,,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay,Other,18818073.0,
138,389102,6,2,,103507229,222284,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells,Other,18818073.0,
139,389103,3,4,,103507229,222284,Inconclusive,,,,,"Selectivity index, ratio of IC50 for against african green monkey VERO cells to MIC for Mycobacterium tuberculosis H37Rv",Other,18818073.0,
140,398791,3,5,,103507229,222284,Inactive,,,,,Antitumor activity against mouse P388 cells xenografted in mouse at 50 to 400 mg/kg,Other,7381509.0,
141,399111,2,4,,103507229,222284,Unspecified,,,,,Growth promotion activity of Phytophthora cactorum assessed as mycelial dry weight at 10 mg/L after 12 days in liquid culture medium,Other,,
142,399112,2,4,,103507229,222284,Unspecified,,,,,Growth promotion activity of Phytophthora cactorum assessed as mycelial dry weight at 10 mg/L after 18 days in liquid culture medium,Other,,
143,399113,2,4,,103507229,222284,Unspecified,,,,,Effect on Phytophthora cactorum growth assessed as colony diameter at 10 mg/L after 6 days in solid culture medium,Other,,
144,399154,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human 9KB cells,Other,,
145,399960,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human Lu1 cells,Other,15043409.0,
146,399961,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human LNCAP cells,Other,15043409.0,
147,399962,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against human MCF7 cells,Other,15043409.0,
148,399963,5,1,,103507229,222284,Unspecified,,,,,Cytotoxicity against HUVEC,Other,15043409.0,
149,402361,3,11,,103507229,222284,Inactive,544257.0,2099.0,,,Activity at human estrogen receptor expressed in transgenic Arabidopsis plant at 400 uM by pER8-GFP reporter assay,Other,16038533.0,
150,402936,6,7,,103507229,222284,Unspecified,116241312.0,1576.0,100.0,IC50,Inhibition of human CYP3A4 by radiometric assay,Confirmatory,15270556.0,
151,402937,6,7,,103507229,222284,Unspecified,84028191.0,1565.0,100.0,IC50,Inhibition of human CYP2D6 by radiometric assay,Confirmatory,15270556.0,
152,405575,8,1,,103507229,222284,Unspecified,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 2 weeks by agar dilution method,Other,18471021.0,
153,426207,3,4,,103507229,222284,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells upto 50 uM by neutral red assay,Other,19555121.0,
154,426208,3,4,,103507229,222284,Unspecified,,,,,Cytotoxicity against pig LLC-PK11 cells upto 50 uM by neutral red assay,Other,19555121.0,
155,426210,3,4,,103507229,222284,Unspecified,,,,,Cytotoxicity against human SW1353 cells by neutral red assay,Other,19555121.0,
156,426211,3,6,,103507229,222284,Inactive,,,,,Inhibition of SP1-dependent luciferase expression,Other,19555121.0,
157,426212,3,4,,103507229,222284,Inactive,,,,,Cytotoxicity against human HepG2 cells upto 50 uM by neutral red assay,Other,19555121.0,
158,426213,3,4,,103507229,222284,Inactive,,,,,Cytotoxicity against human SK-MEL cells upto 50 uM by neutral red assay,Other,19555121.0,
159,426214,3,4,,103507229,222284,Inactive,,,,,Cytotoxicity against human KB cells upto 50 uM by neutral red assay,Other,19555121.0,
160,426215,3,4,,103507229,222284,Inactive,,,,,Cytotoxicity against human BT549 cells upto 50 uM by neutral red assay,Other,19555121.0,
161,426216,3,4,,103507229,222284,Inactive,,,,,Cytotoxicity against human SKOV3 cells upto 50 uM by neutral red assay,Other,19555121.0,
162,437575,3,4,,103507229,222284,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as cell survival at 5 uM after 24 hrs by MTT assay,Other,19716700.0,
163,437576,3,4,,103507229,222284,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as cell survival at 10 uM after 24 hrs by MTT assay,Other,19716700.0,
164,437577,3,4,,103507229,222284,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as cell survival at 20 uM after 24 hrs by MTT assay,Other,19716700.0,
165,437578,3,4,,103507229,222284,Unspecified,,,,,Cytotoxicity against human HepG2 cells assessed as cell survival at 100 uM after 24 hrs by MTT assay,Other,19716700.0,
166,437579,3,4,,103507229,222284,Active,,,,,Induction of AMPK phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose,Other,19716700.0,
167,437580,3,11,,103507229,222284,Active,20455502.0,2932.0,,,Induction of GSK3-beta phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose,Other,19716700.0,
168,437581,3,4,,103507229,222284,Active,,,,,Increase in glycogen synthesis in human HepG2 cells assessed as incorporation of [14C]glucose in to cellular glycogen pools at 10 uM after 60 mins in presence of 33 mM glucose,Other,19716700.0,
169,437582,3,4,,103507229,222284,Active,,,,,Induction of glucose uptake in human HepG2 cells at 10 uM in presence of 33 mM 2-[14C]-DOG by scintillation counting,Other,19716700.0,
170,458321,3,11,,103507229,222284,Inactive,30316367.0,3291.0,,,Inhibition of human recombinant 11beta-HSD2 expressed in HEK293 cells assessed as reduction of cortisone to cortisol conversion at 20 uM by scintillation counting,Other,20100662.0,
171,471323,5,2,,103507229,222284,Inactive,,,,IC50,Cytotoxicity against human A2780 cells after 4 days by MTT assay,Confirmatory,19702283.0,
172,471324,9,5,,103507229,222284,Inactive,131467.0,5770.0,,IC50,Inhibition of GST-tagged human PTP1B,Confirmatory,19702283.0,
173,471325,6,2,,103507229,222284,Inactive,,,,IC50,Antiviral activity against HIV-1 NL4-3 expressing VSV-G envelope infected in human 293T cells assessed as inhibition of viral replication after 48 hrs by Luciferase reporter gene assay,Confirmatory,19702283.0,
174,485350,1,2,,92125975,222284,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
175,492967,1,2,,92125975,222284,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
176,493033,1,2,,92125975,222284,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
177,493140,1,1,,103913594,222284,Inactive,,,,,Screening small molecules to find regulators of human embryonic stem cell survival.,Screening,,
178,540299,1,2,,92125975,222284,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
179,551461,1,4,,103507229,222284,Inactive,,,,,Antioxidant activity assessed as peroxyl radical scavenging activity at 1 to 2 uM by ORAC assay,Other,21194938.0,
180,551462,1,4,,103507229,222284,Inactive,,,,,Antioxidant activity assessed as copper ion radical scavenging activity at 2 uM,Other,21194938.0,
181,551463,1,4,,103507229,222284,Inactive,,,,,Metal chelating activity of the compound at 1 to 2 uM,Other,21194938.0,
182,588211,2,3,,103507229,222284,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
183,588212,2,3,,103507229,222284,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
184,588213,2,3,,103507229,222284,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
185,588519,1,2,,92125975,222284,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
186,588834,2,1,,144205067,222284,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
187,589667,1,4,,103507229,222284,Unspecified,,,,,Induction of NGF production in rat C6 cells at 20 uM after 24 hrs by ELISA relative to untreated control,Other,21353549.0,
188,589668,1,4,,103507229,222284,Unspecified,,,,,Cytotoxicity against rat C6 cells assessed as viable cells at 20 uM after 24 hrs by MTT assay,Other,21353549.0,
189,602314,1,2,,92125975,222284,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
190,614100,2,3,,103507229,222284,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus ATCC 9144 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
191,614101,2,3,,103507229,222284,Unspecified,,,,,Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
192,614102,2,3,,103507229,222284,Unspecified,,,,,Antimicrobial activity against Pseudomonas aeruginosa NCTC 10332 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
193,614103,2,3,,103507229,222284,Unspecified,,,,,Antimicrobial activity against Candida albicans ATCC 10231 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
194,614104,2,3,,103507229,222284,Unspecified,,,,,Antimicrobial activity against Escherichia coli ATCC 11229 after 24 hrs using thiazoyl blue by agar overlay bioautography method,Other,21813280.0,
195,624349,1,2,,121363646,222284,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
196,632581,1,4,,103507229,222284,Inactive,,,,,Antiinflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated TNF-alpha production up to 50 uM preincubated for 1 hr before LPS-stimulation measured after 16 hrs by ELISA,Other,22071304.0,
197,632582,1,4,,103507229,222284,Inactive,,,,,Antiinflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL-6 production up to 50 uM preincubated for 1 hr before LPS-stimulation measured after 16 hrs by ELISA,Other,22071304.0,
198,632583,1,4,,103507229,222284,Inactive,,,,,Antiinflammatory activity in C57BL/6 mouse BMDC assessed as inhibition of LPS-stimulated IL-12p40 production up to 50 uM preincubated for 1 hr before LPS-stimulation measured after 16 hrs by ELISA,Other,22071304.0,
199,634866,1,4,,103507229,222284,Unspecified,,,,,"Antidiabetic activity in STZ-induced diabetic rat model assessed as reduction in glucose-6-phosphatase at 20 mg/kg, po qd for 21 days",Other,22078765.0,
200,634867,1,4,,103507229,222284,Unspecified,,,,,"Antidiabetic activity in STZ-induced diabetic rat model assessed as reduction in glycosylated haemoglobin at 20 mg/kg, po qd for 21 days",Other,22078765.0,
201,634868,1,4,,103507229,222284,Unspecified,,,,,"Antidiabetic activity in STZ-induced diabetic rat model assessed as increase in plasma insulin level at 20 mg/kg, po qd for 21 days",Other,22078765.0,
202,634869,1,5,,103507229,222284,Unspecified,,,,,"Antidiabetic activity in STZ-induced diabetic rat model assessed as increase in liver glycogen at 20 mg/kg, po qd for 21 days",Other,22078765.0,
203,634870,1,4,,103507229,222284,Unspecified,,,,,"Antidiabetic activity in STZ-induced diabetic rat model assessed as increase in muscle glycogen at 20 mg/kg, po qd for 21 days",Other,22078765.0,
204,634871,1,4,,103507229,222284,Unspecified,,,,,"Antidiabetic activity in STZ-induced diabetic rat model assessed as increase in glucose 6 phosphate dehydrogenase at 20 mg/kg, po qd for 21 days",Other,22078765.0,
205,651631,4,1,,144205067,222284,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
206,651632,4,1,,144205067,222284,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
207,651633,4,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
208,651634,4,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
209,652048,1,2,,144205067,222284,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
210,652051,1,1,,144205067,222284,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
211,658063,2,3,,103507229,222284,Unspecified,,,61.0,IC50,Cytotoxicity against human ECV304 cells after 72 hrs by Hoechst 33258 staining based fluorescence assay,Confirmatory,22503361.0,
212,658064,2,3,,103507229,222284,Unspecified,,,472.0,IC50,Membranolytic activity in human ECV304 cells assessed as leakage of intracellular lactate dehydrogenase after 2 hrs by spectrophotometry,Confirmatory,22503361.0,
213,658065,2,2,,103507229,222284,Active,,,19.0,EC50,Reduction in surface tension in 0.1 M PBS after 10 mins by Wilhelmy plate method using tensitometer,Confirmatory,22503361.0,
214,658066,1,2,,103507229,222284,Unspecified,,,,,Critical micellar concentration of the compound in 0.1 M PBS after 10 mins by Wilhelmy plate method using tensitometer,Other,22503361.0,
215,671761,1,2,,103507229,222284,Inactive,,,,,Inhibition of SARS coronavirus nsP13 helicase activity expressed in Escherichia coli Rosetta assessed inhibition of DNA unwinding activity at 10 uM by FRET assay,Other,22578462.0,
216,671762,1,2,,103507229,222284,Inactive,,,,,Inhibition of HCV NS3 helicase overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of DNA unwinding activity at 10 uM by FRET assay,Other,22578462.0,
217,671764,1,2,,103507229,222284,Inactive,,,,,Inhibition of HCV NS3 helicase ATP hydrolysis activity overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of inorganic phosphate release by AM/MG-based colometric analysis in the presence of M13 ssDNA,Other,22578462.0,
218,680929,1,8,,103507229,222284,Unspecified,238054374.0,5243.0,,,TP_TRANSPORTER: Flow cytometry in MDR1-expressing NIH3T3 cells,Other,12488046.0,
219,681449,1,8,,103507229,222284,Unspecified,68052328.0,26357.0,,,TP_TRANSPORTER: Flow cytometry in lymphocytes from Mdr1a/b-/- mice,Other,12488046.0,
220,681727,1,8,,103507229,222284,Unspecified,12585136.0,83569.0,,,"TP_TRANSPORTER: inhibition of taurocholate uptake (taurocholate: 2 uM, beta-sitosterol: 10 uM) in membrane vesicles of Bsep-expressing S9f cells",Other,12488046.0,
221,681863,1,8,,103507229,222284,Unspecified,52783101.0,17250.0,,,TP_TRANSPORTER: Flow cytometry in lymphocytes from Mdr1a/b(-/)- mice,Other,12488046.0,
222,686977,2,1,,49699231,222284,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
223,686978,1,1,,144205067,222284,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
224,686979,1,1,,144205067,222284,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
225,697852,1,7,,103507229,222284,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
226,697853,1,7,,103507229,222284,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
227,720516,2,1,,144205067,222284,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
228,720532,1,1,,144205067,222284,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
229,720533,1,1,,144205067,222284,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
230,720552,2,1,,144205067,222284,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
231,720579,2,1,,144205067,222284,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
232,720580,1,1,,144205067,222284,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
233,720634,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
234,720635,2,1,,144205067,222284,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
235,720637,2,1,,144205067,222284,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
236,720674,2,2,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
237,720675,2,2,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
238,720678,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
239,720679,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
240,720680,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
241,720681,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
242,720682,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
243,720683,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
244,720684,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
245,720685,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
246,720686,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
247,720687,2,2,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
248,720691,4,1,,144205067,222284,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
249,720692,3,1,,144205067,222284,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
250,720693,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
251,720717,1,3,,92125975,222284,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
252,720719,2,1,,144205067,222284,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
253,720725,2,1,,144205067,222284,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
254,743012,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
255,743014,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
256,743015,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
257,743033,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
258,743035,2,1,,144205067,222284,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
259,743036,2,1,,144205067,222284,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
260,743040,3,1,,144205067,222284,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
261,743041,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
262,743042,3,1,,144205067,222284,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
263,743053,2,1,,144205067,222284,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
264,743054,2,1,,144205067,222284,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
265,743063,2,1,,144205067,222284,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
266,743064,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
267,743065,3,1,,144205067,222284,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
268,743066,3,1,,144205067,222284,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
269,743067,2,1,,144205067,222284,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
270,743069,2,1,,144205067,222284,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
271,743074,2,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
272,743075,2,1,,144205067,222284,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
273,743077,2,1,,144205067,222284,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
274,743078,2,1,,144205067,222284,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
275,743079,3,1,,144205067,222284,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
276,743080,3,1,,144205067,222284,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
277,743081,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
278,743083,3,1,,144205067,222284,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
279,743084,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
280,743085,3,1,,144205067,222284,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
281,743086,3,1,,144205067,222284,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
282,743091,2,1,,144205067,222284,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
283,743094,3,1,,144205067,222284,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
284,743122,2,1,,144205067,222284,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
285,743139,2,1,,144205067,222284,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
286,743140,2,1,,144205067,222284,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
287,743244,1,1,,144205067,222284,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
288,746436,1,1,,103507229,222284,Unspecified,,,50.0,IC50,Antiplasmodial activity against Plasmodium falciparum W2,Confirmatory,23562058.0,
289,746437,1,1,,103507229,222284,Unspecified,,,50.0,IC50,Antiplasmodial activity against Plasmodium falciparum D6,Confirmatory,23562058.0,
290,780288,1,1,,103507229,222284,Inactive,,,,,Effect on [3H]cholesterol liberation from cell membrane of human ECV304 cells after 1 hr by liquid scintillation counting,Other,24084294.0,
291,780289,1,1,,103507229,222284,Inactive,,,,,Reduction in [3H]cholesterol uptake in human ECV304 cells after 1 hr by liquid scintillation counting,Other,24084294.0,
292,780290,1,1,,103507229,222284,Unspecified,,,61.0,IC50,Cytotoxicity against human ECV304 cells after 72 hrs by MTT assay,Confirmatory,24084294.0,
293,780291,1,1,,103507229,222284,Unspecified,,,472.0,IC50,Membrane toxicity against human ECV304 cells after 2 hrs by LDH release assay,Confirmatory,24084294.0,
294,977599,1,1,,103507229,222284,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
295,977602,1,2,,103507229,222284,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
296,1095934,1,2,,103507229,222284,Unspecified,,,,,Cytotoxicity against Homo sapiens (human) HeLa cells after 48 hr by MTT assay,Other,,
297,1095935,1,2,,103507229,222284,Inactive,,,,,Inhibition of TNFalpha-induced NF-kappaB activity (unknown origin) expressed in HeLa cells cotreated with compound and 10 ng/ml TNF-alpha for 24 hr by reporter gene assay,Other,,
298,1097036,1,2,,103507229,222284,Unspecified,,,,,Antiamoebic activity against Entamoeba histolytica,Other,,
299,1098509,1,1,,103507229,222284,Inactive,,,,,Insecticidal activity against Drosophila melanogaster larvae fed with compound incorporated diet assessed as mortality at 5 to 100 ug/ml after 72 hr by not choice test (Rvb = 0%),Other,23731643.0,
300,1100849,1,1,,103507229,222284,Unspecified,,,,,Toxicity in Artemia (brine shrimps) larvae,Other,10820107.0,
301,1114570,1,2,,103507229,222284,Inactive,,,,,"Antidepressant activity in albino Mus musculus (mouse) assessed as reduction in immobility time at 100 mg/kg, ip administered 30 min prior to testing by forced-swim test relative to control",Other,,
302,1114571,1,2,,103507229,222284,Inactive,,,,,"Antidepressant activity in albino Mus musculus (mouse) assessed as reduction in immobility time at 50 mg/kg, ip administered 30 min prior to testing by forced-swim test relative to control",Other,,
303,1114572,1,2,,103507229,222284,Unspecified,,,,,"Stimulation of central nervous system in albino Mus musculus (mouse) assessed as increase in rearing behaviour at 50 mg/kg, ip administered 30 min prior to testing by open-feild test relative to control",Other,,
304,1114574,1,2,,103507229,222284,Unspecified,,,,,"Stimulation of central nervous system in albino Mus musculus (mouse) assessed as increase in number of lines crossed at 50 mg/kg, ip administered 30 min prior to testing by open-feild test relative to control",Other,,
305,1114576,1,2,,103507229,222284,Active,,,,,"Anxiolytic activity in albino Mus musculus (mouse) assessed as increase in number of open arm enteries at 100 mg/kg, ip administered 30 min prior to testing by elevated-plus maze test relative to control",Other,,
306,1114577,1,2,,103507229,222284,Active,,,,,"Anxiolytic activity in albino Mus musculus (mouse) assessed as increase in number of open arm enteries at 50 mg/kg, ip administered 30 min prior to testing by elevated-plus maze test relative to control",Other,,
307,1114578,1,2,,103507229,222284,Inactive,,,,,"Anxiolytic activity in albino Mus musculus (mouse) assessed as increase in time spent on open arm at 100 mg/kg, ip administered 30 min prior to testing by elevated-plus maze test relative to control",Other,,
308,1114580,1,2,,103507229,222284,Inactive,,,,,"Anxiolytic activity in albino Mus musculus (mouse) assessed as increase in time spent on open arm at 50 mg/kg, ip administered 30 min prior to testing by elevated-plus maze test relative to control",Other,,
309,1115779,1,2,,103507229,222284,Inconclusive,,,,,Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells assessed as growth inhibition by MTT assay,Other,,
310,1115780,1,4,,103507229,222284,Inactive,115717.0,1509.0,,,Inhibition of cathepsin D (unknown origin) using hemoglobin as substrate at 20 ug/mL after 30 min by spectrophotometric analysis,Other,,
311,1116310,1,2,,103507229,222284,Unspecified,,,,,"Antipyretic activity in Wistar albino Rattus norvegicus (rat) assessed as brewer's yeast-induced rectal tempeRattus norvegicus (rat)ure at 10 mg/kg, po measured at 23 hr (Rvb = 39.1+/- 0.18 degC)",Other,,
312,1116311,1,2,,103507229,222284,Unspecified,,,,,"Antipyretic activity in Wistar albino Rattus norvegicus (rat) assessed as brewer's yeast-induced rectal tempeRattus norvegicus (rat)ure at 10 mg/kg, po measured at 22 hr (Rvb = 39.1+/- 0.18 degC)",Other,,
313,1116312,1,2,,103507229,222284,Unspecified,,,,,"Antipyretic activity in Wistar albino Rattus norvegicus (rat) assessed as brewer's yeast-induced rectal tempeRattus norvegicus (rat)ure at 10 mg/kg, po measured at 21 hr (Rvb = 39.1+/- 0.18 degC)",Other,,
314,1116313,1,2,,103507229,222284,Unspecified,,,,,"Antipyretic activity in Wistar albino Rattus norvegicus (rat) assessed as brewer's yeast-induced rectal tempeRattus norvegicus (rat)ure at 10 mg/kg, po measured at 20 hr (Rvb = 39.1+/- 0.18 degC)",Other,,
315,1116314,1,2,,103507229,222284,Unspecified,,,,,"Antipyretic activity in Wistar albino Rattus norvegicus (rat) assessed as brewer's yeast-induced rectal tempeRattus norvegicus (rat)ure at 10 mg/kg, po measured at 19 hr (Rvb = 39.3 +/- 0.11 degC)",Other,,
316,1116322,1,2,,103507229,222284,Unspecified,,,,,"Anti-inflammatory activity in Swiss albino Mus musculus (mouse) assessed as inhibition of cotton pellet-induced granuloma formation at 10 mg/kg, po administered QD for 5 days measured at 1 hr post-last dose relative to control",Other,,
317,1116324,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as mortality up to 100 mg/kg, po measured up to 72 hr",Other,,
318,1116325,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as presence of secretions up to 100 mg/kg, po measured up to 24 hr relative to control",Other,,
319,1116326,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as diarrhea up to 100 mg/kg, po measured up to 24 hr relative to control",Other,,
320,1116327,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as convulsions up to 100 mg/kg, po measured up to 24 hr relative to control",Other,,
321,1116328,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as tremors up to 100 mg/kg, po measured up to 24 hr relative to control",Other,,
322,1116329,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as ataxia up to 100 mg/kg, po measured up to 24 hr relative to control",Other,,
323,1116330,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as lethargy up to 100 mg/kg, po measured up to 24 hr relative to control",Other,,
324,1116331,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as effect on mobility up to 100 mg/kg, po measured up to 24 hr relative to control",Other,,
325,1116332,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as abdominal constriction up to 100 mg/kg, po measured up to 24 hr relative to control",Other,,
326,1116333,1,2,,103507229,222284,Unspecified,,,,,"Toxicity in Swiss albino Mus musculus (mouse) assessed as weight loss up to 100 mg/kg, po measured up to 24 hr relative to control",Other,,
327,1118023,1,3,,103507229,222284,Active,1352311.0,1803.0,28.84,IC50,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,Confirmatory,,
328,1159524,1,1,,144205067,222284,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
329,1159550,3,1,,252402747,222284,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
330,1159607,2,1,,312595979,222284,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
331,1224817,1,1,,101391,222284,Inactive,,,,,Assays to identify small molecules inhibitory for eIF4E expression,Other,26144883.0,
332,1256912,1,1,,103507229,222284,Unspecified,21903432.0,3417.0,,,Inhibition of human IDH1 R132H mutant expressed in IPTG-induced Escherichia coli BL21 cells assessed as oxidation of NADPH to NADP+ after 5 mins by spectrophotometry,Other,26508549.0,
333,1256913,1,1,,103507229,222284,Unspecified,21903432.0,3417.0,,,Inhibition of human IDH1 expressed in IPTG-induced Escherichia coli BL21 cells assessed as reduction of NADP+ to NADPH after 5 mins by spectrophotometry,Other,26508549.0,
334,1259310,1,1,,321949139,222284,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
335,1259310,1,1,,333495013,222284,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
336,1259344,1,1,,144205067,222284,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
337,1259355,1,1,,144205067,222284,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
338,1259356,1,1,,144205067,222284,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
339,1259389,1,1,,175607826,222284,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
340,1259423,1,2,,355009241,222284,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
